Jess is a European qualified patent attorney in the Life Sciences and Chemistry group, specialising in the biosciences.

Jess' practice has a particular focus on cancer immunotherapy, particularly in the fields of T-cell engineering and antibody-based therapeutics. Jess also regularly works on matters relating to RNA-based therapeutics and microbiology, with a strong practice in approaches to harness and modify the microbiome. Aside from the life sciences, Jess also has significant experience representing and advising clients in the fast-moving food tech industry.

EPO opposition and prosecution are the cornerstones of Jess' practice, and her extensive academic experience means she enjoys working on highly complex and technical subject matter.

Jess holds a PhD in Neuroscience, and prior to joining Kilburn & Strode worked as a postdoctoral research fellow at the University of Edinburgh. During that time, Jess published numerous academic papers, with her research highlighting the contribution of oxidative stress and glial cell activation to neurodegeneration in vascular dementia.

Qualifications

PhD in Neuroscience – University of Edinburgh (2017)
MSc in Integrative Neuroscience – University of Edinburgh (2013)
BSc in Neuroscience and Psychology – University of Manchester (2011)
 

Memberships

Chartered Institute of Patent Attorneys (CIPA) – student member
The Institute of Professional Representatives before the European Patent Office (EPI) – student member

T. Leonard, J. Duncombe, The worldwide pharma response to coronavirus – Part 2: Promising leads, Kilburn & strode, (2020) 

N. Bassil, J. Duncombe, Patentability of plant products obtained by an essentially biological process, Kilburn & strode, (2019) 

Cookies improve the way our website works. By using this website you are agreeing to our use of cookies. For more information see our cookie policy I accept